about
Detection of heart disease by open access echocardiography: a retrospective analysis of general practice referrals.Does population screening for Chlamydia trachomatis raise anxiety among those tested? Findings from a population based chlamydia screening study.Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.Effects of genetic screening on perceptions of health: a pilot study.Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.Cholesterol screening and cholesterol lowering treatmentStress and cancer surveys: attitudes of participants in a case-control study.The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study GroupFinding diabetics--a method of screening in general practiceThe UMDS MSc in general practice: attainment of intended outcomes.Patients' responses to risk information about the benefits of treating hypertension.Inviting infrequent attenders to attend for a health check: costs and benefits.Experiences of patients with false positive results from colorectal cancer screening.Factors affecting women's response to an invitation to attend for a second breast cancer screening examinationPatients not seen in three years: will invitations for health checks be of benefit?Provision of health promotion clinics in relation to population need: another example of the inverse care law?Elderly people's views of an annual screening assessment.Why is preventive medicine exempted from ethical constraints?Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm"Am I carrier?" The patient's lived experience of thrombophilia genetic screening and its outcome.Screening in practice: Reducing the psychological costs.Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?Role of research in development of organisation and structure of general practice.Acceptability of opportunistic screening for occult gastrointestinal blood loss.Lifestyle advice in general practice: rates recalled by patients.Neuropathic pain in the community: more under-treated than refractory?Cancer prevention: setting the scene.Balancing proactive and reactive care.Screening for cardiovascular risk in general practiceScreening: reasons to be cautious.Telling patients there is nothing wrong.Testing asymptomatic patients for Chlamydia trachomatis.Problems that patients feel are appropriate to discuss with their GPs.Are patients in favour of general health screening?
P2860
Q30486776-F3E16307-07A4-4744-B31F-62DC0C5C19F6Q33241081-F405B2E8-35E0-45E9-8F38-D0D0A2AA12B3Q33325717-10DFA899-DD3B-430A-9335-C6C41B0315EDQ33593622-ABFD79B8-5188-48D9-BD74-8F8306C2806AQ33631450-6AB79F77-1945-4815-A258-ED24D6A30405Q33691286-BE0E29A6-311C-4EB2-9E63-0E94209BCC3CQ33700644-52D85A92-B4D4-4BD6-B44D-98D4EA185D5EQ34055210-62CB543C-3F92-4C4E-931B-E3163FC00252Q34214720-F1D04416-4376-48A3-AD50-17FE89290504Q34216032-AD12EECF-F0F0-4CBE-AF22-8ED4EF91ED86Q34220002-19F9BCA7-7A65-471A-BB9F-9FCB1235D06EQ34367742-3730B386-329B-4027-809A-AAC8733287F2Q34368275-D0B7184C-BE1A-4FF4-A180-255222004756Q34369402-49825A32-5ADF-49A9-A539-5A61D079D07BQ34369433-87FD4459-8985-4DF9-9450-E9ECC8B8D8A7Q34369991-C6B7423D-0D1A-4176-AF6C-8068C07D08D1Q34371569-B9B8F0DE-47D5-4A75-B7D3-9A7C6E21FF76Q34382653-7D96097F-4E61-469E-98F9-37CCBF1F17EAQ34451586-2977C189-ED59-4358-B641-5BABE3A6B797Q34712649-6CD46522-76DA-4A2F-B385-B256430D67FAQ35136009-FE7855D9-3FFB-44E5-9E75-53A267D01995Q35169855-E1214AC1-FAD5-408C-8961-F1D1FA55F0AAQ35179315-D7382102-E473-4DBC-B4B0-0C375A6B12F0Q35179544-3A1EF24B-F365-41BE-9F15-BFA410F15015Q35819796-FBFD329B-9AD9-4F37-B200-339C7BE1B936Q35823436-03D04873-A7F8-4291-8BB5-FC80894490B1Q36778307-629258E3-2483-47E5-9593-D8507DBAAB25Q36885897-D73010FD-CC00-4860-8C21-74D3274ABC0AQ36920743-C908701A-CFBA-4114-A922-956FE135CB4DQ42561047-637C0FDD-140B-4174-955C-5BBAA9DED77CQ43153830-1A45D24F-6E0A-4CE2-A3F0-7D3ADDE8BDBEQ43189176-418EA21F-55AB-4050-85C1-E21E1A881036Q46939637-66ACB8A4-61F3-451C-8EA0-5F8BD98B2590Q50939377-6214898A-F4ED-4440-A177-E7F506A3F497Q54296562-6FAA3ECD-8B8B-4149-A45F-C1FC79714084
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Can health screening damage your health?
@ast
Can health screening damage your health?
@en
type
label
Can health screening damage your health?
@ast
Can health screening damage your health?
@en
prefLabel
Can health screening damage your health?
@ast
Can health screening damage your health?
@en
P2860
P1476
Can health screening damage your health?
@en
P2093
P2860
P304
P577
1989-05-01T00:00:00Z